Carevive is a health technology company focusing on care management and patient engagement solutions to improve the quality of life and clinical outcomes of cancer patients. Sign up for our newsletter here.
This study demonstrates the feasibility of gathering PROs with real-world data among a cohort of patients with AML using a remote symptom monitoring platform, across baseline prognostic and therapeutic factors.
Previous studies have shown that frailty scores aid in better patient assessment and in advising treatment strategies for Acute Myeloid Leukemia (AML) (Jamy, et al., 2021), and Multiple Myeloma (Nathwani, et al., 2017, 2019). This study aims to evaluate the impact of frailty status on treatment choices among breast cancer patients.
Women undergoing treatment for breast cancer experience both disease- and treatment-related symptoms. Remote symptom management (RSM) programs allow real-time symptom documentation, earlier intervention, and opportunities to improve quality of life and decrease symptom burden. Prior studies have focused on the supportive care needs of women with advanced breast cancer.